LRRK2 and Parkinson disease: Across 15 hiPSC studies, evidence of impaired protein degradation in LRRK2, PRKN, GBA, DJ-1, SNCA, and sporadic PD lines has been reported26,27,29,36,45,48–50,53,56,58,63,69,75.